logo-loader
AIM:ONC

Oncimmune

Market:
AIM
Market Cap:
£78.75 m
Price
124.00 GBX
Change
-1.98%
52 weeks high
139.95
52 weeks low
30.00

In brief

Oncimmune's range of diagnostic tests profile the body’s immune response to detect evidence of the body’s natural response to cancer, which can detect cancer on average four years earlier than standard clinical diagnosis.